Navigation Links
Hebrew University research holds promise for development of new osteoporosis drug
Date:10/4/2010

Jerusalem, October 4, 2010 Researchers at the Hebrew University of Jerusalem have discovered a group of substances in the body that play a key role in controlling bone density, and on this basis they have begun development of a drug for prevention and treatment of osteoporosis and other bone disorders.

The findings of the Hebrew University researchers have just been published in the American journal PNAS (Proceedings of the National Academy of Sciences).

The research group working on the project is headed by Prof. Itai Bab of the Bone Laboratory and Prof. Raphael Mechoulam of the Institute of Drug Research at the Hebrew University, and includes post-doctoral fellow Reem Smoum and doctoral students Gary Millman, Orr Ofek, Alon Bajayo, Joseph Tam, Vardit Kram and associates from the United States.

Osteoporosis is the most widespread degenerative disease in the Western world and is expressed in the loss of bone mass and the weakening of bone structure, contributing to frequent bone fractures, disability and even death. The loss of bone mass in osteoporosis is caused by internal destruction of the bone tissue. With age, the quantity of bone tissue that is lost is greater than that which is created, which leads to the decrease in bone density.

In their current research, the researchers found that the bone cells produce a series of substances composed of fatty acids and amino acids called "acyl amides." They then analyzed their precise chemical composition, created synthetic versions of them, and examined their effect on bone cell cultures.

In experiments on mice, they discovered that one of the compounds in the group of synthetic materials, oleoyl serine, increased bone density in both healthy and osteoporotic mice. They also found that the osteoporotic mice were actually missing the oleoyl serine in their bones. These findings, say the researchers, can serve as the basis for new drugs that can both prevent bone loss and boost bone formation and in this way reverse loss of bone tissue in osteoporosis patients.

Development of such a drug has begun in the laboratories of Prof. Mechoulam and Prof. Bab. Yissum, the technology transfer company of the Hebrew University, has submitted a patent application based on their work and is seeking a commercial partner for further development.

Prof. Mechoulam expressed confidence that their work showing bone mass accumulation would lead soon to the development of an effective osteoporosis drug. Drugs in use until now have worked to prevent further bone loss or to encourage bone formation, but none of them are able to accomplish both functions together as this new formula can do, said Prof. Bab.

The researchers noted that research in this field until now has been based primarily on proteins and genetics. Now, the Hebrew University researchers say, they have opened a new approach, called "skeletal lipidomics" based on the examination of substances in the skeleton containing fatty acids and amino acids. This has great significance in understanding the regulation of metabolism in bone and in other body tissues, they say.


'/>"/>

Contact: Jerry Barach
jerryb@savion.huji.ac.il
972-258-82904
The Hebrew University of Jerusalem
Source:Eurekalert  

Related biology news :

1. Scent on demand: Hebrew University scientists enhance the scent of flowers
2. Hebrew University scientists reveal mechanism that triggers differentiation of embryo cells
3. Hebrew University professors work leads to FDA approval for product
4. Hebrew University researchers neutralize tumor growth in embryonic stem cell therapy
5. Promising new treatment for Alzheimers suggested based on Hebrew University research
6. Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
7. Ben-Gurion U. developing new computer techniques to analyze historic Hebrew and Arabic documents
8. Alert status area in brain discoved by Hebrew University scientists
9. Regulatory role of key molecule discovered at Hebrew U.
10. Hebrew University, American researchers show trigger to stem cell differentiation
11. JDRF, Pfizer, Hadassah Medical and the Hebrew University announce collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hebrew University research holds promise for development of new osteoporosis drug
(Date:6/15/2016)... 2016 Transparency Market Research ... Market by Application Market - Global Industry Analysis Size Share ... the report, the  global gesture recognition market  was ... is estimated to grow at a CAGR of ... Increasing application of gesture recognition technology ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... June 2, 2016   The Weather Company , an ... Ads, an industry-first capability in which consumers will be able ... to ask questions via voice or text and receive relevant ... Marketers have long sought an advertising solution ... can be personal, relevant and valuable; and can scale across ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... Nov. 30, 2016  GenomOncology today announced the appointment of ... Medical Affairs.  Dr. Coleman will oversee clinical ... proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists ... data and clinical decision support, from quality control through reporting. ... , , ...
(Date:11/30/2016)... SEATTLE , Nov. 30, 2016  The ... Allen Cell Collection: the first publicly available collection ... stem cells that target key cellular structures with ... Medical Research, these powerful tools are a crucial ... cells to better understand what makes human cells ...
(Date:11/30/2016)... , 30. November 2016   ... hat heute die Unterzeichnung einer Reihe von ... zufolge wird Evotec AG Screeningleistungen für Mercks ... bereitstellen. Der Zugriff auf diese Bibliotheken in ... eröffnet einen schnelleren Weg zur Ermittlung und ...
(Date:11/30/2016)... ... November 30, 2016 , ... Energetiq Technology, ... introduces the 5th generation, ultra-bright, Laser-Driven Light Source, the EQ-77, at the MRS ... technology, the EQ-77 offers higher radiance and irradiance from a truly broadband white ...
Breaking Biology Technology: